Virus Transmission to People Recently Bitten or With a History of Monkey Bites "SIMVIR
NCT07097480 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2025-12-15
Summary
Nonhuman primates (NHPs) constitute an important reservoir of infectious agents, some of which have emerged in human populations as deadly pathogens. Human exposure to the biological fluids of NHPs - particularly through bites - can result in the transmission of several viruses. Only the rabies virus is currently targeted by post-exposure prophylaxis following an injury caused by an NHP.
The objective of the study is to investigate the prevalence of STLV-1 and SFV infections following a nonhuman primate bite.
Conditions
- Bites Monkey
Interventions
- PROCEDURE
-
Blood samples collection
Blood samples of 40 ml will be taken.
- PROCEDURE
-
Saliva samples collection
Saliva samples will be collected
Sponsors & Collaborators
-
Institut Pasteur
lead INDUSTRY
Principal Investigators
-
Patrick HOCHEDEZ, Dr · Institut Pasteur Medical Center
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-08-14
- Primary Completion
- 2026-12-31
- Completion
- 2028-08-31
Countries
- France
Study Locations
More Related Trials
-
Evaluation of Effectiveness and Safety of LC16m8 Mpox Vaccine in the Democratic Republic of Congo (DRC)
NCT07093489 ·Status: NOT_YET_RECRUITING
-
Study of Purified Vero Rabies Vaccine and Rabies Human Diploid Cell Vaccine in a Simulated Rabies Post-exposure Regimen
NCT01877395 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study Investigating the Safety and Immune Responses After Immunization With Investigational Monkeypox Vaccines
NCT05988203 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Recombinant VSV (rVSV)-Marburg Virus Vaccine Candidate (PHV01) in Healthy Adult Subjects
NCT06265012 ·Status: COMPLETED ·Phase: PHASE1
-
Purified Vero Rabies Vaccine-Serum Free Compared to Human Diploid Cell Vaccine in a Pre-exposure Prophylaxis Regimen
NCT01930357 ·Status: COMPLETED ·Phase: PHASE2
-
Monovalent Chimpanzee Adenoviral-Vectored Marburg Virus Vaccine in Healthy Adults
NCT05817422 ·Status: COMPLETED ·Phase: PHASE2
-
JYNNEOS Smallpox Vaccine in Adult Healthcare Personnel at Risk for Mpox in the Democratic Republic of the Congo
NCT02977715 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Evaluating the Safety and Immunogenicity of MVA Strain Monkeypox Attenuated Live Vaccine
NCT06771479 ·Status: RECRUITING ·Phase: PHASE1
-
Safety and Immunogenicity of Two Intradermal Rabies Vaccine Regimens Administered With and Without Human Rabies Immunoglobulin in Subjects ≥ 1 Years of Age
NCT02177032 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Marburg Virus Vaccine in Healthy Adults
NCT06620003 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy/Effectiveness, Safety, and Immunogenicity of LC16m8 Mpox Vaccine in Colombia
NCT06223919 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Comparison of Purified Vero Rabies Vaccine, Serum Free With Human Diploid Cell Vaccine in Pre-exposure Use
NCT01784874 ·Status: COMPLETED ·Phase: PHASE2
-
Simplifying the Rabies Pre-exposure Vaccination
NCT01388985 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized Phase II Trial to Compare the Safety and Neutralizing Activity of CL184 in Combination With Rabies Vaccine vs. HRIG or Placebo in Combination With Rabies Vaccine in Healthy Adult Subjects
NCT00656097 ·Status: COMPLETED ·Phase: PHASE2
-
Imovax® Rabies and VERORAB® Immunogenicity and Safety After One Week 2-sites Intradermal or 1-site Intramuscular Pre-Exposure Prophylaxis Regimens, Followed by a Simulated Post-Exposure Prophylaxis Regimen at One Year
NCT03700242 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Purified Vero Rabies Vaccine Serum Free Compared With Reference Purified Vero Rabies Vaccine in Healthy Adults
NCT00948272 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity Study of Recombinant Human Rabies Immunoglobin (rhRIG) in Combination With Rabies Vaccine for Human Use With Human Rabies Immune Globulin (HRIG) in Combination With Rabies Vaccine for Human Use in Healthy Adult Subjects.
NCT02559921 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial of Freeze-dried Human Rabies Vaccine (Without Serum Vero Cells)
NCT05969626 ·Status: UNKNOWN ·Phase: PHASE3
-
Cohort Study of Healthcare Workers Receiving Imvanex®
NCT03745131 ·Status: COMPLETED
-
Rabies mAb CBB 1 Combination Vaccine in Healthy People With Antibody Neutralization Activity and Safety Phase Clinical Trials
NCT06548139 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Safety, Pharmacokinetics, and Pharmacodynamic Testing of Rabies mAb CBB 1
NCT05832073 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine in Healthy Adults
NCT03051386 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study to Learn About COVID-19 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Participants Ages 12 Through 64 Years Considered at Higher Risk of Severe COVID-19, and Participants Ages ≥65 Years
NCT07069309 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate GR1801's Efficacy and Safety
NCT05846568 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity Assessment of Subjects Receiving Rabies Post-exposure Prophylaxis in Cambodia
NCT05684185 ·Status: COMPLETED